WASHINGTON DC – New data show that replacement therapy with Cinryze (C1 inhibitor-nf) infusion reverses all abnormalities of the plasma bradykinin-forming pathway and fibrinolysis that are responsible for the swelling attacks in patients with hereditary angioedema (HAE).
Read full article…

Other Headlines

• Four Washington DC Landmarks Featured in The Lost Symbol
• The First Draft: End of an era for GM
• The First Draft: Now he’s talking!
• Disney Brings Holiday Travel to You
• Miracle bras: hooters and shooters?
• Live Nation and Ticketmaster: “Don’t stop Believing”
• The inaugural: a proud Legocy!